GLP-1 Market
LLY $1208.74 ▲ +3.6% NVO $38.12 ▲ +0.2% PFE $29.21 ▲ +3.0% VKTX $25.47 ▼ -4.4% KLRA $10.74 ▼ -0.3% GPCR $21.88 ▼ -1.9% RHHBY $55.67 ▲ +3.5%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Multiple injections of insulin

Company
Helsinki University Central Hospital
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
3 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

3 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 15, 2026

Find a Clinical Trial Near Me

See recruiting studies for Multiple injections of insulin and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT03463564

    Insulin Pump vs Multiple Daily Injections of Insulin and Glyco-metabolic Control in Type 1 Diabetic Patients

    Not yet reported University of Campania Luigi Vanvitelli 150 participants Est. completion 2026-12 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Recruiting NCT NCT06236607

    Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes

    Not yet reported Boston Medical Center 140 participants Est. completion 2028-09 2 sites
    Other conditions: Diabetes Mellitus, Type 1, Diabetes Complications
    View official trial listing →
  • Recruiting NCT NCT07423637

    The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Control and Comorbidities, and Cost-effectiveness of AID Treatment

    Not yet reported Helsinki University Central Hospital 100 participants Est. completion 2028-12-31 2 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Terminated NCT NCT02682940

    T1 Diabetes Hypoglycemia Prevention Pilot

    Not yet reported InSpark Technologies, Inc. 4 participants Est. completion 2016-12 1 site
    Other conditions: Diabetes Mellitus, Type 1, Hypoglycemia
    View official trial listing →
  • Terminated NCT NCT02906891

    A Pilot Study of Nocturnal Hypoglycemia Prevention in Type 1 Diabetes Using the Vigilant Diabetes Management Companion

    Not yet reported InSpark Technologies, Inc. 13 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Hypoglycemia, Diabetes Mellitus, Type 1
    View official trial listing →
  • Status unknown NCT NCT03112538

    Improving Glycaemic Control in Malaysian Patients With Type 2 Diabetes Mellitus With Insulin Pump Therapy

    Not yet reported Clinical Research Centre, Malaysia 118 participants Est. completion 2018-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT04013919

    Observational, Data Collection Study for Subjects With Diabetes Using Insulin Injections

    DreaMed Diabetes 260 participants Est. completion 2020-04 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT04043260

    DreaMed Advisor Pro System in Subjects With Type 1 Diabetes Treated With MDI Therapy

    Not yet reported DreaMed Diabetes 35 participants Est. completion 2021-04-30 1 site
    Other conditions: Insulin-dependent Diabetes Mellitus, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT04538352

    Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D

    Not yet reported The Cleveland Clinic 60 participants Est. completion 2023-11-01 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04796779

    The Pediatric Artificial Pancreas (PEDAP) Trial of Control-IQ Technology in Young Children in Type 1 Diabetes

    Not yet reported Marc Breton 102 participants Est. completion 2022-07-31 3 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT05923827

    Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults

    Not yet reported Insulet Corporation 189 participants Est. completion 2026-02-12 19 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Withdrawn NCT NCT05985135

    Impact of Insulin Deprivation and Hyperglycemia on Plasma Protein Synthesis in People With Type 1 Diabetes Mellitus

    Not yet reported Mayo Clinic Est. completion 2026-07-31 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT06449677

    Bionic Pancreas in CFRD

    Not yet reported Jaeb Center for Health Research 150 participants Est. completion 2027-05-31 16 sites
    Other conditions: Cystic Fibrosis-related Diabetes
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Multiple injections of insulin, Multiple daily injections of insulin

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.